Physician

Dong Won Kim

According to 2025 Medicare claims, Dong Kim (NPI: 1831695204) practices internal medicine in the Frederick-Gaithersburg-Bethesda, MD market, with the plurality of this provider's patient population coming from Montgomery, MD. This provider's primary affiliated billing organization is MARYLAND ONCOLOGY HEMATOLOGY, P.A. (NPI: 1821271032; TIN: 113652573) and primary practice location at 20904-7917.

Kim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 183 traditional Medicare patients, billed 25,940 HCPCS/CPT codes, and received $371,254 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 328 prescription claims across 90 beneficiaries totaling $493,206 in drug costs, led by Mekinist (Trametinib Dimethyl Sulfoxide). DME data shows 13 claims. Open Payments data shows 58 records totaling $1,648. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,192 to $493,206. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$186K$371K2024 Medicare payment: $371,254 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
202418325,940$371,254

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$247K$493K2018 Drug cost: $3,192 (USD; Tot_Drug_Cst)2019 Drug cost: $2,911 (USD; Tot_Drug_Cst)2020 Drug cost: $11,549 (USD; Tot_Drug_Cst)2021 Drug cost: $162,956 (USD; Tot_Drug_Cst)2022 Drug cost: $331,935 (USD; Tot_Drug_Cst)2023 Drug cost: $200,028 (USD; Tot_Drug_Cst)2024 Drug cost: $493,206 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181128$3,192
20191334$2,911
20201842$11,549
202173176$162,956
202283236$331,935
202376212$200,028
202490328$493,206

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$863$1.7K2023 Medicare payment: $1,725 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $955 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R40$1,725
2024N/R13$955

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less3354$114
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3235$75
96372Injection of drug or substance under skin or into muscle4550$13
80053Blood test, comprehensive group of blood chemicals4492$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count51105$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MekinistTrametinib Dimethyl Sulfoxide13390$202,531
EliquisApixaban13697$12,735
Oxycodone HclOxycodone Hcl36367$576
DexamethasoneDexamethasone16256$390
HydroxyureaHydroxyurea14588$208

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R13$955

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.58$1,648Alexion Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Dong Won Kim?

Tedicare shows public-source Medicare data for Dong Won Kim (NPI 1831695204), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dong Won Kim have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Dong Won Kim?

Dong Won Kim is linked to MARYLAND ONCOLOGY HEMATOLOGY, P.A. (billing NPI 1821271032) in the available physician profile data.

Does Dong Won Kim have Open Payments data?

Dong Won Kim has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.